ATC Group: B03XA01 Erythropoietin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B03XA01 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B03 Antianemic preparations
3 B03X Other antianemic preparations
4 B03XA Other antianemic preparations
5 B03XA01 Erythropoietin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 1,000 [iU]

Active ingredients in B03XA01

Active Ingredient Description
Epoetin alfa

Epoetin alfa is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. Epoetin alfa is involved in all phases of erythroid development, and has its principal effect at the level of erythroid precursors.

Epoetin zeta

Epoetin zeta is a recombinant human erythropoietin. Erythropoietin (EPO) is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. The 2 are indistinguishable on the basis of functional assays.

Related product monographs

Title Information Source Document Type  
ABSEAMED Solution for injection in a pre-filled syringe European Medicines Agency (EU) MPI, EU: SmPC
BINOCRIT Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
BIOPOIN Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
EPOGEN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
EPORATIO Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
RETACRIT Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
SILAPO Solution for injection in pre-filled syringe European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Canada (CA)

Hong Kong (HK)

Israel (IL)

Italy (IT)

Japan (JP)

Netherlands (NL)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.